Cargando…
Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma
Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer, and ~30% of patients with LUAD develop cancer recurrence after surgery. The present study aimed to identify and validate biomarkers that may be used to monitor recurrence following LUAD surgery. Data from patients with LUAD were d...
Autores principales: | Zhu, Ji, Lu, Qijue, Li, Bin, Li, Huafei, Wu, Cong, Li, Chunguang, Jin, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130048/ https://www.ncbi.nlm.nih.gov/pubmed/34025787 http://dx.doi.org/10.3892/ol.2021.12781 |
Ejemplares similares
-
Expression of Uroplakin Ib and Uroplakin III Genes in Tissues and Peripheral Blood of Patients with Transitional Cell Carcinoma
por: Yuasa, Takeshi, et al.
Publicado: (1998) -
Reduced Expression of Uroplakin 1A Is Associated with the Poor Prognosis of Gastric Adenocarcinoma Patients
por: Zheng, Yan, et al.
Publicado: (2014) -
Generation of divergent uroplakin tetraspanins and their partners during vertebrate evolution: identification of novel uroplakins
por: DeSalle, Rob, et al.
Publicado: (2014) -
Uroplakins in the Lower Urinary Tract
por: Lee, Gilho
Publicado: (2011) -
Uroplakins and their potential applications in urology
por: Matuszewski, Michal Andrzej, et al.
Publicado: (2016)